The effect of metformin on mortality rates and exercise tolerance in patients with heart failure and type 2 diabetes.

Back

ESC Premium Access

The effect of metformin on mortality rates and exercise tolerance in patients with heart failure and type 2 diabetes.

Session: Drug therapy of heart failure

Topic: Pharmacologic therapy

Speaker: Mr A. Retwinski (Lodz, PL)

Event: ESC Congress 2016

Congress Presentation

About the speaker

Mr Arkadiusz Retwinski

Medical University of Lodz, Lodz (Poland)

0 follower

8 more presentations in this session

Are beta-blockers needed in patients after primary prevention implantable cardioverter-defibrillator? A multicenter population-based cohort study.

Speaker: Professor L. Fauchier (Tours, FR)

Non-withdrawal of beta-blockers in acute decompensated chronic and de-novo heart failure is associated with lower in-hospital and 3-months mortality: Findings from the GULF-CARE

Speaker: Assistant Professor C. Abi Khalil (Doha, QA)

Access

Abstract

Beta-blockers, ACE/ARB and MRA at discharge and outcome after hospitalization of heart failure in octogenarians with HFPEF and HFREF: a report from the BIO-HF registry

Speaker: Professor J. De Sutter (Ghent, BE)

Fingerprint of the renin-angiotensin-system during ARNI therapy in patients with systolic heart failure

Speaker: Doctor R. Wurm (Vienna, AT)

Anti hypertrophic effects of LCZ696 in chronic cardiac pressure overload

Speaker: Mr E. Sjaastad Norden (Oslo, NO)

Access the full session

Drug therapy of heart failure

Speakers: Mr A. Retwinski, Professor L. Fauchier, Assistant Professor C. Abi Khalil, Professor J. De Sutter, Doctor R. Wurm...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

The effect of metformin on mortality rates and exercise tolerance in patients with heart failure and type 2 diabetes.

About the speaker

Mr Arkadiusz Retwinski

8 more presentations in this session

Are beta-blockers needed in patients after primary prevention implantable cardioverter-defibrillator? A multicenter population-based cohort study.

Non-withdrawal of beta-blockers in acute decompensated chronic and de-novo heart failure is associated with lower in-hospital and 3-months mortality: Findings from the GULF-CARE

Beta-blockers, ACE/ARB and MRA at discharge and outcome after hospitalization of heart failure in octogenarians with HFPEF and HFREF: a report from the BIO-HF registry

Fingerprint of the renin-angiotensin-system during ARNI therapy in patients with systolic heart failure

Anti hypertrophic effects of LCZ696 in chronic cardiac pressure overload

Access the full session

Drug therapy of heart failure

About the event

ESC Congress 2016

ESC 365 is supported by